October 2023
-
10.12.2023
Prescription Medicines Medicines U.S. FDA Approves Pfizer’s BRAFTOVI® + MEKTOVI® for BRAF V600E-Mutant Metastatic Non-Small Cell Lung Cancer
-
10.05.2023
-
10.04.2023
Financial Finance Pfizer Declares Fourth-Quarter 2023 Dividend
September 2023
-
09.22.2023
-
09.19.2023
-
09.19.2023
-
09.18.2023
-
09.12.2023
-
09.11.2023
-
09.05.2023
August 2023
-
08.30.2023
-
08.30.2023